Oct 20, 2026 04:00PM

Sep 18, 2026 08:00AM

Sep 18, 2026 08:00AM

Jul 29, 2026 04:05PM

Jul 27, 2026 01:22AM

Jul 22, 2026 04:05PM

Jun 17, 2026 04:28PM Corcept resubmits NDA for relacorilant to treat Cushing's syndrome

Jun 17, 2026 04:28PM

Jun 6, 2026 04:48PM

Jun 6, 2026 04:45PM

May 29, 2026 04:36PM

May 29, 2026 04:33PM

May 27, 2026 08:01AM

May 27, 2026 08:00AM Corcept to Resubmit its New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome

Apr 30, 2026 04:06PM

Apr 30, 2026 04:05PM

Apr 30, 2026 04:05PM

Apr 23, 2026 04:05PM

Apr 21, 2026 01:09PM

Apr 21, 2026 01:09PM

Apr 10, 2026 04:45PM Corcept presents survival data for ovarian cancer drug Lifyorli

Apr 10, 2026 04:45PM

Mar 30, 2026 04:21AM

Mar 28, 2026 02:45PM

Mar 25, 2026 06:03PM

Mar 25, 2026 12:43PM

Mar 25, 2026 12:43PM

Mar 25, 2026 10:33AM FDA approves Corcept's relacorilant combination for platinum-resistant ovarian cancer

Mar 18, 2026 12:08PM

Mar 17, 2026 11:34PM

Mar 17, 2026 11:34PM

Mar 17, 2026 09:00AM

Mar 16, 2026 11:03AM

Mar 16, 2026 03:27AM

Mar 13, 2026 09:51PM Corcept faces securities fraud lawsuit over FDA drug rejection

Mar 13, 2026 09:51PM

Mar 13, 2026 01:43PM

Mar 13, 2026 09:00AM

Mar 12, 2026 12:08PM

Mar 12, 2026 09:00AM

Mar 12, 2026 04:32AM

Mar 11, 2026 09:43PM Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - C

Mar 10, 2026 10:20PM

Mar 10, 2026 10:19PM

Mar 10, 2026 09:08AM

Mar 10, 2026 09:00AM

Mar 9, 2026 02:37AM

Mar 6, 2026 09:52PM

Mar 6, 2026 04:00PM Class Action Filed Against Corcept Therapeutics Incorporated (CORT) Seeking Recovery for Investors – Contact The Gross Law Firm

Mar 6, 2026 12:03PM

335,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All